These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 34365576)

  • 1. Exosomes as cell-derivative carriers in the diagnosis and treatment of central nervous system diseases.
    Shetgaonkar GG; Marques SM; DCruz CEM; Vibhavari RJA; Kumar L; Shirodkar RK
    Drug Deliv Transl Res; 2022 May; 12(5):1047-1079. PubMed ID: 34365576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of exosomes in the pathogenesis, diagnosis, and treatment of central nervous system diseases.
    Fan Y; Chen Z; Zhang M
    J Transl Med; 2022 Jun; 20(1):291. PubMed ID: 35761337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Roles of Exosomes in Huntington's Disease.
    Ananbeh H; Vodicka P; Kupcova Skalnikova H
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal miRNAs in central nervous system diseases: biomarkers, pathological mediators, protective factors and therapeutic agents.
    Xia X; Wang Y; Huang Y; Zhang H; Lu H; Zheng JC
    Prog Neurobiol; 2019 Dec; 183():101694. PubMed ID: 31542363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Trends in Nanotechnology Toward CNS Diseases: Lipid-Based Nanoparticles and Exosomes for Targeted Therapeutic Delivery.
    Cardoso AM; Guedes JR; Cardoso AL; Morais C; Cunha P; Viegas AT; Costa R; Jurado A; Pedroso de Lima MC
    Int Rev Neurobiol; 2016; 130():1-40. PubMed ID: 27678173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of exosome lipids in central nervous system diseases.
    Wang G; Wang Y; Liu N; Liu M
    Rev Neurosci; 2020 Oct; 31(7):743-756. PubMed ID: 32681787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of exosomal microRNAs in central nervous system diseases.
    Yu Y; Hou K; Ji T; Wang X; Liu Y; Zheng Y; Xu J; Hou Y; Chi G
    Mol Cell Biochem; 2021 May; 476(5):2111-2124. PubMed ID: 33528706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomes in head and neck cancer: Roles, mechanisms and applications.
    Cao J; Zhang M; Xie F; Lou J; Zhou X; Zhang L; Fang M; Zhou F
    Cancer Lett; 2020 Dec; 494():7-16. PubMed ID: 32781015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcellular brain drug delivery: A review on recent advancements.
    Azarmi M; Maleki H; Nikkam N; Malekinejad H
    Int J Pharm; 2020 Aug; 586():119582. PubMed ID: 32599130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Investigation into the identities of circulating exosomes].
    Yoshioka Y; Ochiya T
    Rinsho Ketsueki; 2016; 57(10):1874-1880. PubMed ID: 27725583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases.
    Rufino-Ramos D; Albuquerque PR; Carmona V; Perfeito R; Nobre RJ; Pereira de Almeida L
    J Control Release; 2017 Sep; 262():247-258. PubMed ID: 28687495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomaterial-mediated CNS delivery of diagnostic and therapeutic agents.
    Biddlestone-Thorpe L; Marchi N; Guo K; Ghosh C; Janigro D; Valerie K; Yang H
    Adv Drug Deliv Rev; 2012 May; 64(7):605-13. PubMed ID: 22178615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymeric nanoparticles for drug delivery to the central nervous system.
    Patel T; Zhou J; Piepmeier JM; Saltzman WM
    Adv Drug Deliv Rev; 2012 May; 64(7):701-5. PubMed ID: 22210134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-derived nanovesicle-mediated drug delivery to the brain: Principles and strategies for vesicle engineering.
    Liang Y; Iqbal Z; Lu J; Wang J; Zhang H; Chen X; Duan L; Xia J
    Mol Ther; 2023 May; 31(5):1207-1224. PubMed ID: 36245129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CNS-Derived Blood Exosomes as a Promising Source of Biomarkers: Opportunities and Challenges.
    Hornung S; Dutta S; Bitan G
    Front Mol Neurosci; 2020; 13():38. PubMed ID: 32265650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiology of the intrathecal bolus: the leptomeningeal route for macromolecule and particle delivery to CNS.
    Papisov MI; Belov VV; Gannon KS
    Mol Pharm; 2013 May; 10(5):1522-32. PubMed ID: 23316936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and therapeutic potentials of exosomes in CNS diseases.
    Kawikova I; Askenase PW
    Brain Res; 2015 Aug; 1617():63-71. PubMed ID: 25304360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomes: a role for naturally occurring nanovesicles in cancer growth, diagnosis and treatment.
    Srivastava A; Filant J; Moxley KM; Sood A; McMeekin S; Ramesh R
    Curr Gene Ther; 2015; 15(2):182-92. PubMed ID: 25537774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Small Extracellular Vesicles on Lymphoblast Trafficking across the Blood-Cerebrospinal Fluid Barrier In Vitro.
    Erb U; Hikel J; Meyer S; Ishikawa H; Worst TS; Nitschke K; Nuhn P; Porubsky S; Weiss C; Schroten H; Adam R; Karremann M
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32752027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.